Burden and health care resource utilization in neovascular age-related macular degeneration -: Findings of a multicountry study

被引:114
|
作者
Soubrane, Gisele
Cruess, Alan
Lotery, Andrew
Pauleikhoff, Daniel
Mones, Jordi
Xu, Xiao
Zlateva, Gergana
Buggage, Ronald
Conlon, John
Goss, Thomas F.
机构
[1] Univ Paris 12, Dept Ophthalmol, Ctr Hosp Intercommunal, Creteil, France
[2] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada
[3] Univ Southampton, Div Clin Neurosci, Southampton, Hants, England
[4] St Franziskus Hosp, Dept Ophthalmol, Munster, Germany
[5] Inst Microcirugia Ocular Barcelona, Barcelona, Spain
[6] Covance Market Access Serv Inc, Gaithersburg, MD USA
[7] Pfizer Ophthalm, New York, NY USA
[8] Covance Inc, Princeton, NJ USA
关键词
D O I
10.1001/archopht.125.9.1249
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To describe the burden of bilateral neovascular age-related macular degeneration (NV-AMD) on patient-reported functioning and health resource utilization. Methods: A cross-sectional study of 401 patients with bilateral NV-AMD and 471 elderly control subjects without AMD was conducted in 5 countries. Subjects completed a telephone survey, including the National Eye Institute 25-Item Visual Function Questionnaire, the EuroQol instrument, the Hospital Anxiety and Depression Scale, and history of falls, fractures, and health care resource utilization. Results: The mean age for patients with NV-AMD was 78.1 years, and 65% were women. The patients reported 45% worse vision-related functioning, 13% worse overall wellbeing, and 30% more anxiety and 42% more depression symptoms than controls after adjusting for covariates (all, P <. 001). The effect of NV-AMD was also observed as a doubled fall rate (16% vs 8% [P <. 001]) and a quadrupled need for assistance with daily activities (29% vs 7% [P <. 001]) in the patients compared with controls. Conclusions: The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.
引用
收藏
页码:1249 / 1254
页数:6
相关论文
共 50 条
  • [21] Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group
    Spaide, Richard F.
    Jaffe, Glenn J.
    Sarraf, David
    Freund, K. Bailey
    Sadda, Srinivas R.
    Staurenghi, Giovanni
    Waheed, Nadia K.
    Chakravarthy, Usha
    Rosenfeld, Philip J.
    Holz, Frank G.
    Souied, Eric H.
    Cohen, Salomon Y.
    Querques, Giuseppe
    Ohno-Matsui, Kyoko
    Boyer, David
    Gaudric, Alain
    Blodi, Barbara
    Baumal, Caroline R.
    Li, Xiaoxin
    Coscas, Gabriel J.
    Brucker, Alexander
    Singerman, Lawrence
    Luthert, Phil
    Schmitz-Valckenberg, Steffen
    Schmidt-Erfurth, Ursula
    Grossniklaus, Hans E.
    Wilson, David J.
    Guymer, Robyn
    Yannuzzi, Lawrence A.
    Chew, Emily Y.
    Csaky, Karl
    Mones, Jordi M.
    Pauleikhoff, Daniel
    Tadayoni, Ramin Ramin
    Fujimoto, James
    OPHTHALMOLOGY, 2020, 127 (05) : 616 - 636
  • [22] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [23] Pegaptanib for neovascular age-related macular degeneration
    Gragoudas, ES
    Adamis, AP
    Cunningham, ET
    Feinsod, M
    Guyer, DR
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27): : 2805 - 2816
  • [24] Management of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Pruente, Christian
    PROGRESS IN RETINAL AND EYE RESEARCH, 2007, 26 (04) : 437 - 451
  • [25] Imaging in Neovascular Age-Related Macular Degeneration
    Gess, Adam J.
    Fung, Anne E.
    Rodriguez, Jorge G.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 225 - 233
  • [26] Radiotherapy for neovascular age-related macular degeneration
    Evans, Jennifer R.
    Sivagnanavel, Vasuki
    Chong, Victor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [27] Aflibercept for neovascular age-related macular degeneration
    Sarwar, Salman
    Clearfield, Elizabeth
    Soliman, Mohamed Kamel
    Sadiq, Mohammad Ali
    Baldwin, Andrew J.
    Hanout, Mostafa
    Agarwal, Aniruddha
    Sepah, Yasir J.
    Do, Diana V.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [28] Bevacizumab for Neovascular Age-Related Macular Degeneration
    Silva, Aline
    Furlan, Luiz
    Elias, Flavia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 75 - 76
  • [29] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [30] β-blockers and Neovascular Age-related Macular Degeneration
    Yeung, Ling
    Huang, Ting-Shuo
    Lin, Yun-Hsuan
    Hsu, Kuang-Hung
    Huang, Jerry Chien-Chieh
    Sun, Chi-Chin
    OPHTHALMOLOGY, 2017, 124 (03) : 409 - 411